Big news: ZepBound™ (tirzepatide) is officially approved and available in Canada as of July 2025. That means Canadians looking for a clinically proven, once-weekly weight loss medication finally have access to this groundbreaking GLP-1/GIP therapy—without needing to use…
With cloudcure, you can start prioritizing your health today without wait or referrals, addressing health concerns early on before they snowball into something bigger.